sch 34826 has been researched along with ozagrel in 1 studies
| Studies (sch 34826) | Trials (sch 34826) | Recent Studies (post-2010) (sch 34826) | Studies (ozagrel) | Trials (ozagrel) | Recent Studies (post-2010) (ozagrel) |
|---|---|---|---|---|---|
| 31 | 2 | 0 | 529 | 31 | 37 |
| Protein | Taxonomy | sch 34826 (IC50) | ozagrel (IC50) |
|---|---|---|---|
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 3.43 | |
| Thromboxane-A synthase | Homo sapiens (human) | 0.0864 | |
| Thromboxane-A synthase | Rattus norvegicus (Norway rat) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuhashi, N; Yajima, A | 1 |
1 other study(ies) available for sch 34826 and ozagrel
| Article | Year |
|---|---|
[Enzyme inhibitor in the treatment of preeclampsia].
Topics: Atrial Natriuretic Factor; Dioxolanes; Dipeptides; Female; Humans; Methacrylates; Pre-Eclampsia; Pregnancy; Thromboxane-A Synthase | 1991 |